IBERE PHARMACEUTICALS Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q4 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Ibere Pharmaceuticals quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2020 to Q1 2022.
  • Ibere Pharmaceuticals Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$324K, a 27.6% increase year-over-year.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$324K +$123K +27.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q1 2021 -$447K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$3.54K Oct 22, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.